DAVA Oncology (@davaonc) 's Twitter Profile
DAVA Oncology

@davaonc

DAVA Oncology is a strategic consulting company committed to delivering high quality oncology education and expanding access novel cancer therapies.

ID: 2612301463

linkhttp://www.davaonc.com/ calendar_today08-07-2014 20:29:33

2,2K Tweet

1,1K Takipçi

1,1K Takip Edilen

DAVA Oncology (@davaonc) 's Twitter Profile Photo
DAVA Oncology
@davaonc

2 months ago

At #DAVAWhistler, Dr. Jacob Appelbaum Fred Hutch Cancer Center discusses Decoy-Resistant Interleukin-18 (DR-18) for relapse or pre-emptive treatment of MRD after AlloHCT for AML or MDS. The DR. DREAM (NCT06492707) trial tests the safety, side effects, and best dose of DR-18.

At #DAVAWhistler, Dr. Jacob Appelbaum <a href="/fredhutch/">Fred Hutch Cancer Center</a> discusses Decoy-Resistant Interleukin-18 (DR-18) for relapse or pre-emptive treatment of MRD after AlloHCT for AML or MDS. The DR. DREAM (NCT06492707) trial tests the safety, side effects, and best dose of DR-18.